Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Oregon bill would require drugmakers to report all patient-assistance programs, sponsors say
Summary
Sen. Deb Patterson and supporters told the Senate Committee on Health Care SB 1528 (dash-2) would expand manufacturer reporting to cover all patient-assistance programs so policymakers can see how coupons and other assistance affect insurance and state costs; pharma groups warned of confidentiality and limited evidence the change will reduce patient costs.
Sen. Deb Patterson urged the Senate Committee on Health Care on Feb. 11 to advance Senate Bill 1528 with its dash-2 amendment, saying the change would close loopholes that currently let drugmakers report only a fraction of patient-assistance programs. "We know that Oregonians are getting squeezed by rising health care costs and people in our communities are struggling to pay for needed medications," Patterson said, arguing broader reporting will help the state identify which drugs drive affordability problems.
Supporters including the consumer group OSPR and insurers told the committee expanded reporting would give analysts and policy makers usable data about how manufacturers’ co-pay and patient-assistance programs affect…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
